Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

VAPO

Vapotherm (VAPO)

Vapotherm Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:VAPO
FechaHoraFuenteTítuloSímboloCompañía
29/04/202415:22Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NYSE:VAPOVapotherm Inc
01/04/202415:30Edgar (US Regulatory)Form 8-K - Current reportNYSE:VAPOVapotherm Inc
29/02/202416:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:VAPOVapotherm Inc
27/02/202416:21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:VAPOVapotherm Inc
15/12/202306:00GlobeNewswire Inc.OTC Markets Group Welcomes Vapotherm, Inc. to OTCQXNYSE:VAPOVapotherm Inc
14/12/202317:27PR Newswire (US)Vapotherm Announces Suspension of NYSE Listing Common Stock Expected to Begin Trading Promptly on OTCQXNYSE:VAPOVapotherm Inc
11/12/202305:45PR Newswire (US)Vapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock Application Pending to Transfer Shares to OTCQXNYSE:VAPOVapotherm Inc
28/11/202315:54PR Newswire (US)Vapotherm Educates over 8,000 Clinicians in Respiratory Care MonthNYSE:VAPOVapotherm Inc
08/11/202315:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:VAPOVapotherm Inc
08/11/202315:10PR Newswire (US)Vapotherm Reports Third Quarter 2023 Financial ResultsNYSE:VAPOVapotherm Inc
03/11/202309:53Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:VAPOVapotherm Inc
01/11/202305:45PR Newswire (US)Vapotherm To Report Third Quarter 2023 Financial ResultsNYSE:VAPOVapotherm Inc
04/10/202315:11Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:VAPOVapotherm Inc
04/10/202305:45Business WireComputational Fluid Dynamics (CFD) modeling further distinguishes Vapotherm High Velocity Therapy from generic high flow cannulasNYSE:VAPOVapotherm Inc
25/09/202305:45Business WirePilot Study demonstrates Vapotherm HVNI technology is more effective than standard oxygen therapy for treatment of acute asthma in childrenNYSE:VAPOVapotherm Inc
20/09/202305:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:VAPOVapotherm Inc
08/08/202315:10Business WireVapotherm Reports Second Quarter 2023 Financial ResultsNYSE:VAPOVapotherm Inc
25/07/202315:30Business WireVapotherm To Report Second Quarter 2023 Financial ResultsNYSE:VAPOVapotherm Inc
21/06/202315:16Edgar (US Regulatory)Current Report Filing (8-k)NYSE:VAPOVapotherm Inc
24/05/202315:44Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:VAPOVapotherm Inc
05/05/202315:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NYSE:VAPOVapotherm Inc
05/05/202305:07Edgar (US Regulatory)Notice of Effectiveness (effect)NYSE:VAPOVapotherm Inc
03/05/202315:43Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NYSE:VAPOVapotherm Inc
03/05/202315:10Business WireVapotherm Reports First Quarter 2023 Financial ResultsNYSE:VAPOVapotherm Inc
01/05/202315:19Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:VAPOVapotherm Inc
27/04/202315:30Business WireVapotherm To Report First Quarter 2023 Financial ResultsNYSE:VAPOVapotherm Inc
11/04/202315:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NYSE:VAPOVapotherm Inc
17/03/202315:30Business WireVapotherm Announces NYSE Continued Listing Standard Notice Related to Stock PriceNYSE:VAPOVapotherm Inc
24/02/202315:20Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:VAPOVapotherm Inc
23/02/202315:15Business WireVapotherm Reports Fourth Quarter and Fiscal Year 2022 Financial ResultsNYSE:VAPOVapotherm Inc
 Showing the most relevant articles for your search:NYSE:VAPO

Su Consulta Reciente

Delayed Upgrade Clock